Neuropace, Inc. NPCE Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s other commercial liabilities?
- Neuropace, Inc. (NPCE) reported other commercial liabilities of $9.34M in Q1 2026.
- How has Neuropace, Inc.'s other commercial liabilities changed year-over-year?
- Neuropace, Inc.'s other commercial liabilities increased by 16.0% year-over-year, from $8.06M to $9.34M.
- What is the long-term trend for Neuropace, Inc.'s other commercial liabilities?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s other commercial liabilities has grown at a 15.1% compound annual growth rate (CAGR), from $6.6M to $13.34M.